Viewing Study NCT06318312



Ignite Creation Date: 2024-05-06 @ 8:15 PM
Last Modification Date: 2024-10-26 @ 3:24 PM
Study NCT ID: NCT06318312
Status: COMPLETED
Last Update Posted: 2024-05-08
First Post: 2024-03-12

Brief Title: Effects of Hypoxia on Cognitive Performance
Sponsor: University of Castilla-La Mancha
Organization: University of Castilla-La Mancha

Study Overview

Official Title: Effects of Different Hypoxia Exposures on Cognitive Performance in Healthy Adults
Status: COMPLETED
Status Verified Date: 2024-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: HYPCOG
Brief Summary: The goal of this clinical trial is to determine the effects of different hypoxia exposures FiO2 11 13 15 and 21 on cognitive performance in healthy adults The main questions it aims to answer are

What is the best hypoxia exposure to improve reaction time anticipation attention and memory tasks
Which hypoxia exposure causes the greatest detriments in cognitive function
Detailed Description: Participants will completed four trials in a single-blinded crossover randomised control trial In the first session individuals familiarised with the different cognitive tests and hypoxic exposures In the next four experimental trials separated by 1 week participants arrived at the laboratory and rested in a seated for 10 min The vital signs ie SpO2 HR blood pressure and Lake Louise Score were recorded prior to mask placed and start with in one of the four conditions a PLANOR b FiO215 c FiO213 or FiO211 In this hypoxic condition the participant will spend a total of 45 min of which 30 min was at rest and the other 15 min was performing the cognitive tasks ie memory test gono-go test eriksen flanker test anticipation task and reaction time test

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None